José María
Raya Sánchez
Part Time Assistant Professor (Health Science)
Hospital Universitario de Canarias
San Cristóbal de La Laguna, EspañaPublications in collaboration with researchers from Hospital Universitario de Canarias (62)
2024
2023
-
CNL and aCML should be considered as a single entity based on molecular profiles and outcomes
Blood Advances, Vol. 7, Núm. 9, pp. 1672-1681
-
Granulocytic Sarcoma Mimicking Cholesteatoma: Beware the Temporal Bone in Haematological Patients
ORL, Vol. 85, Núm. 5, pp. 299-304
-
Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis
HemaSphere, Vol. 7, Núm. 1, pp. E818
-
Philadelphia-negative chronic myeloproliferative neoplasm follow-up: when the phone rings. Changes during the COVID-19 pandemic and patient satisfaction. Experience in 30 health centers in Spain
Annals of Hematology, Vol. 102, Núm. 2, pp. 447-456
2022
-
Correction to: Low‑risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera (Annals of Hematology, (2022), 101, 10, (2231-2239), 10.1007/s00277-022-04963-z)
Annals of Hematology
-
Hb Nivaria: A New Hemoglobin Variant with a Shortened α-Globin Chain [α139(HC1)Lys→Stop; HBA1: c.418A>T]
Hemoglobin, Vol. 46, Núm. 6, pp. 344-346
-
Impact of Individual Comorbidities on Survival of Patients with Myelofibrosis
Cancers, Vol. 14, Núm. 9
-
Low-risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera
Annals of Hematology, Vol. 101, Núm. 10, pp. 2231-2239
-
Predictors of thrombosis and bleeding in 1613 myelofibrosis patients from the Spanish Registry of Myelofibrosis
British Journal of Haematology, Vol. 199, Núm. 4, pp. 529-538
-
Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea
Cancer, Vol. 128, Núm. 13, pp. 2441-2448
-
Relevance of early diagnosis in polycythemia vera and essential thrombocythemia: a single center's experience
Revista Clinica Espanola, Vol. 222, Núm. 3, pp. 169-173
2021
-
Allogeneic hematopoietic cell transplantation in older myelofibrosis patients: A study of the chronic malignancies working party of EBMT and the Spanish Myelofibrosis Registry
American Journal of Hematology, Vol. 96, Núm. 10, pp. 1186-1194
-
The risk of thrombosis in essential thrombocythemia is associated with the type of CALR mutation: A multicentre collaborative study
European Journal of Haematology, Vol. 106, Núm. 3, pp. 371-379
2020
-
Clinico-biological characteristics of patients with myelofibrosis: an analysis of 1,000 cases from the Spanish Registry of Myelofibrosis
Medicina Clinica, Vol. 155, Núm. 4, pp. 152-158
2019
-
Comprehensive clinical, molecular and histopathological analysis of bone marrow in chronic myeloproliferative neoplasia
Revista Clinica Espanola, Vol. 219, Núm. 8, pp. 440-444
-
Nasal embryonal rhabdomyosarcoma with bone marrow metastasis simulating acute leukemia: A case report and review of the literature
Revista Espanola de Patologia, Vol. 52, Núm. 2, pp. 87-91
2018
-
Bone marrow trephine biopsy in Hodgkin's lymphoma. Comparison with PET-CT scan in 65 patients
Medicina Clinica, Vol. 150, Núm. 3, pp. 104-106
-
Clinical characteristics, prognosis and treatment of myelofibrosis patients with severe thrombocytopenia
British Journal of Haematology